Vanguard Group
PETX

Vanguard Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,341,398
Closed -$6.92M 4209
2019
Q2
$6.92M Sell
1,341,398
-1,102,226
-45% -$5.69M ﹤0.01% 3057
2019
Q1
$8.8M Buy
2,443,624
+164,294
+7% +$591K ﹤0.01% 2894
2018
Q4
$14M Buy
2,279,330
+235,122
+12% +$1.44M ﹤0.01% 2605
2018
Q3
$11.9M Buy
2,044,208
+75,166
+4% +$439K ﹤0.01% 2831
2018
Q2
$8.37M Buy
1,969,042
+105,563
+6% +$449K ﹤0.01% 2990
2018
Q1
$8.22M Buy
1,863,479
+58,457
+3% +$258K ﹤0.01% 2924
2017
Q4
$9.5M Buy
1,805,022
+61,605
+4% +$324K ﹤0.01% 2845
2017
Q3
$10.7M Sell
1,743,417
-177,173
-9% -$1.09M ﹤0.01% 2775
2017
Q2
$13.9M Sell
1,920,590
-5,964
-0.3% -$43.1K ﹤0.01% 2621
2017
Q1
$10.2M Buy
1,926,554
+235,208
+14% +$1.25M ﹤0.01% 2763
2016
Q4
$12.1M Buy
1,691,346
+182,382
+12% +$1.31M ﹤0.01% 2656
2016
Q3
$14.1M Buy
1,508,964
+238,309
+19% +$2.23M ﹤0.01% 2524
2016
Q2
$8.03M Buy
1,270,655
+214,900
+20% +$1.36M ﹤0.01% 2752
2016
Q1
$5.83M Sell
1,055,755
-26,466
-2% -$146K ﹤0.01% 2887
2015
Q4
$6.04M Buy
1,082,221
+8,916
+0.8% +$49.8K ﹤0.01% 2902
2015
Q3
$9.08M Buy
1,073,305
+95,757
+10% +$810K ﹤0.01% 2654
2015
Q2
$14.8M Buy
977,548
+17,380
+2% +$263K ﹤0.01% 2485
2015
Q1
$15.4M Buy
960,168
+120,558
+14% +$1.93M ﹤0.01% 2440
2014
Q4
$15M Buy
839,610
+108,605
+15% +$1.94M ﹤0.01% 2372
2014
Q3
$7.34M Buy
731,005
+179,704
+33% +$1.8M ﹤0.01% 2639
2014
Q2
$8.61M Buy
551,301
+55,936
+11% +$873K ﹤0.01% 2570
2014
Q1
$9.2M Buy
495,365
+384,717
+348% +$7.14M ﹤0.01% 2536
2013
Q4
$2.11M Buy
110,648
+43,736
+65% +$836K ﹤0.01% 3165
2013
Q3
$1.09M Buy
+66,912
New +$1.09M ﹤0.01% 3337